1. Home
  2. MATH vs PDSB Comparison

MATH vs PDSB Comparison

Compare MATH & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$0.73

Market Cap

39.7M

Sector

Finance

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

N/A

Current Price

$0.22

Market Cap

43.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
PDSB
Founded
2015
2005
Country
Hong Kong
United States
Employees
N/A
10
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
43.4M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
MATH
PDSB
Price
$0.73
$0.22
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
25.8K
2.1M
Earning Date
05-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.22
52 Week High
$4.10
$1.55

Technical Indicators

Market Signals
Indicator
MATH
PDSB
Relative Strength Index (RSI) 38.32 16.80
Support Level N/A N/A
Resistance Level $1.17 $0.77
Average True Range (ATR) 0.07 0.07
MACD -0.01 -0.05
Stochastic Oscillator 19.76 0.10

Price Performance

Historical Comparison
MATH
PDSB

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: